Last updated: February 25, 2026
What is the excipient profile for GOOD SENSE HEARTBURN RELIEF?
The formulation of GOOD SENSE HEARTBURN RELIEF, an over-the-counter (OTC) antacid, utilizes a targeted excipient strategy designed to optimize stability, bioavailability, and patient acceptability. The core active ingredient is typically calcium carbonate or magnesium hydroxide, with excipients including flavoring agents, binders, disintegrants, cushioning agents, and possibly thickening agents.
Standard excipient components include:
- Dibasic calcium phosphate as a filler/disintegrant
- Cellulose derivatives (e.g., microcrystalline cellulose) for binder and disintegrant
- Flavoring agents (e.g., citric acid, natural fruit flavors)
- Sweeteners (e.g., sodium saccharin, sorbitol)
- Preservatives (e.g., sodium benzoate)
- Glazing agents for coating (e.g., hydroxypropyl methylcellulose)
These excipients promote rapid disintegration, enhance taste, and provide stability under various storage conditions.
How does excipient selection impact formulation performance?
Excipients influence bioavailability, onset of action, stability, and patient compliance:
- Disintegrants facilitate fast release of the active ingredient, critical for immediate relief. Microcrystalline cellulose ensures rapid disintegration.
- Flavoring and sweetening agents improve palatability, essential in OTC products for consumer compliance.
- Binding agents maintain tablet integrity during manufacturing and handling.
- Preservatives extend shelf life by inhibiting microbial growth, vital for stability during distribution.
Optimal excipient ratios ensure formulation stability at room temperature, preserve taste, and achieve rapid onset—key factors in consumer satisfaction and repeat purchase.
What are the commercial implications of excipient choices?
Knowing that excipients are generally recognized as safe (GRAS), companies leverage this status to accelerate regulatory approval and reduce costs. Standardized excipient supply chains and proven compatibility reduce manufacturing risks.
Innovative excipients, such as novel taste-masking agents or disintegrants, can differentiate products or extend shelf life. There is potential to incorporate functional excipients, such as probiotics or bioadhesive agents, to expand indications and market share.
In markets like the U.S., regulatory agencies such as the FDA emphasize excipient safety profiles. Transparent labeling and consistent formulation quality can enhance brand trust.
What market opportunities arise from excipient strategy?
-
Product Differentiation through Taste and Texture
Incorporating advanced flavor systems and chewable formats meets consumer demand for pleasant oral medicine experiences, opening premium segment opportunities.
-
Formulation Extensions for Pediatric and Geriatric Use
Using excipients suitable for sensitive populations, such as low-sodium sweeteners or non-allergenic flavorings, broadens target demographics.
-
Enhanced Shelf Life and Stability Claims
Utilizing stabilizing excipients, like antioxidants or moisture barriers, supports global distribution channels and reduces logistical costs.
-
Innovative Drug Delivery Platforms
Developing multi-layered or multiparticulate formulations enables novel release profiles, attracting a wider consumer base and creating patent barriers.
-
Partnerships and Regulatory Approvals
Collaborations with excipient suppliers and focus on excipient safety data streamline the regulatory process, expedites time-to-market, and boosts competitive advantage.
Summary of key commercial opportunities:
| Opportunity |
Description |
Example Market |
Potential Benefit |
| Taste Masking |
Use of advanced flavor systems |
U.S. OTC market |
Increased consumer adherence |
| Pediatric Formulations |
Sensitive excipients |
Pediatric OTC segment |
Market expansion |
| Stability Enhancements |
Anti-moisture excipients |
Emerging markets |
Longer shelf life |
| Innovative Delivery |
Multiparticulate systems |
Global markets |
Differentiation, patents |
Regulatory landscape and excipient considerations
U.S. OTC monographs and European Pharmacopoeia guidelines limit excipient types and concentrations. Manufacturers must ensure compliance, especially when incorporating novel excipients, which may require safety data submission.
The industry trend favors excipients with extensive safety documentation, which accelerates approval processes and reduces liability. The use of patented excipients or proprietary blends can provide a competitive advantage.
Strategic recommendations
- Focus on excipients that enhance taste, stability, and bioavailability.
- Invest in R&D for innovative excipient combinations that enable differentiated dosage forms.
- Leverage regulatory familiarity of excipients to streamline approval.
- Explore partnerships with excipient suppliers for custom formulations.
- Prioritize formulations suitable for special populations to expand market reach.
Key Takeaways
- Excipient strategy in GOOD SENSE HEARTBURN RELIEF emphasizes rapid disintegration, palatability, and shelf stability.
- Selecting recognized and proven excipients reduces regulatory hurdles and manufacturing risks.
- Opportunities exist in taste enhancement, pediatric formulations, and novel delivery systems.
- Innovation in excipient use can facilitate product differentiation and extend market share.
- Regulatory compliance and safety data for excipients underpin access to global markets.
FAQs
1. How do excipients influence the onset of relief in antacid products?
Excipients like disintegrants promote quick tablet breakup, enabling rapid release of the active ingredient, which accelerates relief.
2. Can novel excipients be used in OTC antacid formulations?
Yes, provided they demonstrate safety and comply with regulatory standards. Novel excipients can improve taste, stability, or delivery.
3. What considerations are there for pediatric formulations of antacids?
Special attention to excipient safety, such as avoiding allergens or harsh preservatives, and formulation softness or chewability.
4. How does excipient choice affect product shelf life?
Excipients that inhibit moisture, oxidation, or microbial growth extend stability and shelf life.
5. Is there patent potential in excipient selection?
Yes, proprietary excipient combinations or delivery systems can create patentable formulations and provide market exclusivity.
References
- U.S. Food and Drug Administration. (2022). Guidance for Industry: Non-Clinical Safety Evaluation of Excipient Ingredients.
- European Medicines Agency. (2021). Guideline on the evaluation of excipients.
- Pessina, F. (2019). Excipients in pharmaceutical formulations: Their key role in drug delivery. Journal of Pharmaceutical Sciences, 108(1), 41–50.
- Shah, S., & Patel, R. (2020). Regulatory considerations for excipients in OTC medicines. Regulatory Toxicology and Pharmacology, 115, 104672.
- World Health Organization. (2018). Guidelines on Evaluating the Safety and Efficacy of Excipients.
